Keywords: emea, grants, lilly, enzastaurin, od, status, european

EMEA grants Lilly's enzastaurin OD status

Article | 13 February 2006

Print This

The European Medicines Agency (EMEA) has designated US drug major Elil Lilly's oral anticancer agent enzastaurin an Orphan Drug for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in